Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-25

Clinical Trial Update: Oral Metformin for Treating Melasma in Latin American Women [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a Phase 1/2 study evaluating oral metformin for treating melasma in Latin American women, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: University of Puerto Rico | Conditions: Melasma | Phase 1, Phase 2 | Status: RECRUITING